Effects of steric hindrance and electron density of ester prodrugs on controlling the metabolic activation by human carboxylesterase.
Carboxylesterase
Drug metabolism
Ester
Prodrug
Substrate specificity
Journal
Drug metabolism and pharmacokinetics
ISSN: 1880-0920
Titre abrégé: Drug Metab Pharmacokinet
Pays: England
ID NLM: 101164773
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
03
12
2020
revised:
09
03
2021
accepted:
15
03
2021
pubmed:
20
4
2021
medline:
20
11
2021
entrez:
19
4
2021
Statut:
ppublish
Résumé
Carboxylesterase (CES) plays an important role in the hydrolysis metabolism of ester-type drugs and prodrugs. In this study, we investigated the change in the hydrolysis rate of hCE1 by focusing on the steric hindrance of the ester structure and the electron density. For 26 kinds of synthesized indomethacin prodrugs, the hydrolytic rate was measured in the presence of human liver microsomes (HLM), human small intestine microsomes (HIM), hCE1 and hCE2. The synthesized prodrugs were classified into three types: an alkyl ester type that is specifically metabolized by hCE1, a phenyl ester type that is more easily metabolized by hCE1 than by hCE2, and a carbonate ester type that is easily metabolized by both hCE1 and hCE2. The hydrolytic rate of 1-methylpentyl (hexan-2-yl) ester was 10-times lower than that of 4-methylpentyl ester in hCE1 solution. hCE2 was susceptible to electron density of the substrate, and there was a difference in the hydrolysis rate of up to 3.5-times between p-bromophenyl ester and p-acetylphenyl ester. By changing the steric hindrance and electron density of the alkoxy group, the factors that change the hydrolysis rate by CES were elucidated.
Identifiants
pubmed: 33872946
pii: S1347-4367(21)00012-4
doi: 10.1016/j.dmpk.2021.100391
pii:
doi:
Substances chimiques
Esters
0
Prodrugs
0
Carboxylic Ester Hydrolases
EC 3.1.1.-
Carboxylesterase
EC 3.1.1.1
Indomethacin
XXE1CET956
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100391Informations de copyright
Copyright © 2021 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that there is no conflict of interest.